Milestone Pharmaceuticals Inc. (Nasdaq: MIST), a biopharmaceutical company focused on the development and commercialization of innovative cardiovascular medicines, today announced that Joseph Oliveto, President and Chief Executive Officer, will present at the Canaccord Genuity 40 th Annual Growth Conference on Thursday,
| MONTREAL and CHARLOTTE, N.C., Aug. 6, 2020 /PRNewswire/ -- Milestone Pharmaceuticals Inc. (Nasdaq: MIST), a biopharmaceutical company focused on the development and commercialization of innovative cardiovascular medicines, today announced that Joseph Oliveto, President and Chief Executive Officer, will present at the Canaccord Genuity 40th Annual Growth Conference on Thursday, August 13, 2020 at 1:00 PM ET. The conference will be held in a virtual meeting format. A live webcast of the presentation can be accessed in the News & Events section of Milestone’s website at www.milestonepharma.com. An archived replay of the webcast will be available on the same website for approximately 30 days following the presentation. About Milestone Pharmaceuticals Milestone Pharmaceuticals is a biopharmaceutical company focused on the development and commercialization of innovative cardiovascular medicines. Milestone Pharmaceuticals operates in Canada and the United States. For more information, visit www.milestonepharma.com and follow the Company on Twitter at @MilestonePharma. Contact David Pitts
SOURCE Milestone Pharmaceuticals, Inc. | ||
Company Codes: NASDAQ-NMS:MIST |
View original content to download multimedia:
